| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68083-135-01 | 68083-135 | HUMAN PRESCRIPTION DRUG | Zoledronic Acid | Zoledronic Acid | INJECTION, SOLUTION | INTRAVENOUS | 20160915 | N/A | ANDA | ANDA204217 | Gland Pharma Limited | ZOLEDRONIC ACID | 5 mg/100mL | 1 VIAL, GLASS in 1 CARTON (68083-135-01) / 100 mL in 1 VIAL, GLASS |
| 63323-966-00 | 63323-966 | HUMAN PRESCRIPTION DRUG | Zoledronic Acid | Zoledronic Acid | INJECTION, SOLUTION | INTRAVENOUS | 20170217 | N/A | ANDA | ANDA204217 | Fresenius Kabi USA, LLC | ZOLEDRONIC ACID | 5 mg/100mL | 1 VIAL, GLASS in 1 CARTON (63323-966-00) / 100 mL in 1 VIAL, GLASS |